<DOC>
<DOCNO>EP-0629635</DOCNO> 
<TEXT>
<INVENTION-TITLE>
New 19-nor 11-beta-phenoxysulfonamide or 11-beta-phenoxyalkylsulfonylurea steriod derivatives, a process and intermediates for their production and their use as medicaments and pharmaceuticals containing them
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K3157	A61P538	A61P528	A61P1500	A61K31575	A61P1900	A61P3500	A61P3500	C07J4100	A61P100	C07J4100	A61P100	A61P300	A61K3156	A61P900	A61P2520	A61K31565	A61P1700	A61P542	A61P526	C07J7500	A61P4300	A61P2500	C07J7500	A61P530	C07J4300	A61P912	C07J100	A61P308	A61P1504	A61P1508	A61P546	C07J3100	A61K3158	A61P500	A61P1700	A61P500	A61P310	A61K3158	C07J100	A61P4300	C07J4300	A61P1910	A61P544	A61K3156	A61K3157	A61K31575	A61K31565	A61P532	C07J3100	A61P910	A61P304	A61P3700	A61P3704	A61P1500	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61P	A61P	A61P	A61K	A61P	A61P	A61P	C07J	A61P	C07J	A61P	A61P	A61K	A61P	A61P	A61K	A61P	A61P	A61P	C07J	A61P	A61P	C07J	A61P	C07J	A61P	C07J	A61P	A61P	A61P	A61P	C07J	A61K	A61P	A61P	A61P	A61P	A61K	C07J	A61P	C07J	A61P	A61P	A61K	A61K	A61K	A61K	A61P	C07J	A61P	A61P	A61P	A61P	A61P	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K31	A61P5	A61P5	A61P15	A61K31	A61P19	A61P35	A61P35	C07J41	A61P1	C07J41	A61P1	A61P3	A61K31	A61P9	A61P25	A61K31	A61P17	A61P5	A61P5	C07J75	A61P43	A61P25	C07J75	A61P5	C07J43	A61P9	C07J1	A61P3	A61P15	A61P15	A61P5	C07J31	A61K31	A61P5	A61P17	A61P5	A61P3	A61K31	C07J1	A61P43	C07J43	A61P19	A61P5	A61K31	A61K31	A61K31	A61K31	A61P5	C07J31	A61P9	A61P3	A61P37	A61P37	A61P15	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
The compounds of formula (I): 
<
IMAGE
>
  in which,     R17 and R'17 are such that:     - either R17 and R'17 together form a ketone - or R17 represents a hydroxyl radical or an acyloxy radical and R'17 represents a hydrogen atom or an alkyl, alkenyl or alkynyl radical,   R3 represents a hydrogen atom, an alkyl radical or an acyl radical,    R1 and R2, which may be identical or different, represent     - a hydrogen atom,   - an alkyl radical, which is optionally substituted,   - an acyl radical,   - an aryl or aralkyl radical, which is optionally substituted, - an alkyl, aralkyl or arylcarbamoyl radical, which is optionally substituted, - or form, with the nitrogen atom to which they are attached, a saturated heterocycle which may contain a second hetero atom chosen from N, O and S and which may be substituted,   - or form a dialkylaminomethylene radical,    n is at most equal to 18, and the addition salts of the latter, their preparation, their application as medicaments, the compositions containing them and the new intermediates obtained.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
ROUSSEL UCLAF
</APPLICANT-NAME>
<APPLICANT-NAME>
ROUSSEL UCLAF
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
NIQUE FRANCOIS
</INVENTOR-NAME>
<INVENTOR-NAME>
TEUTSCH JEAN-GEORGES
</INVENTOR-NAME>
<INVENTOR-NAME>
VAN DE VELDE PATRICK
</INVENTOR-NAME>
<INVENTOR-NAME>
NIQUE, FRANCOIS
</INVENTOR-NAME>
<INVENTOR-NAME>
TEUTSCH, JEAN-GEORGES
</INVENTOR-NAME>
<INVENTOR-NAME>
VAN DE VELDE, PATRICK
</INVENTOR-NAME>
</INVENTORS>
<CLAIMS>
The compounds of formula (I): 

 
in which R
17
 and R'
17
 are such that: 

either R
17
 and R'
17
 together form a ketone 
or R
17
 represents a hydroxyl radical, or an acyloxy radical 
having at most 12 carbon atoms and R'
17
 represents a hydrogen 
atom, an alkyl, alkenyl or alkynyl radical having at most 8 

carbon atoms, each of these radicals being optionally 
substituted, 
R
3
 represents a hydrogen atom, a linear, branched or cyclic 
alkyl radical having at most 8 carbon atoms or an acyl 

radical having at most 12 carbon atoms, 
and in which R
1
 and R
2
, identical or different, represent a 
hydrogen atom, a linear, branched or cyclic alkyl radical 

containing 1 to 8 carbon atoms, optionally substituted, an 
acyl radical having at most 12 carbon atoms, an aryl or 

aralkyl radical, each of these radicals being optionally 
substituted, in which the alkyl radical contains at most 6 

carbon atoms and the aryl radical represents a mono or 
polycyclic radical which can contain one or more heteroatoms 

chosen from oxygen, nitrogen and sulphur atoms, 
or R
1
 represents a carbamoyl radical monosubstituted by a  
 

linear, branched or cyclic alkyl radical having at most 8 
carbon atoms, optionally substituted, or by an aryl or 

aralkyl radical, each of these radicals being optionally 
substituted, in which the alkyl radical contains at most 6 

carbon atoms and the aryl radical represents a mono or 
polycyclic radical which can contain one or more heteroatoms 

chosen from oxygen, nitrogen and sulphur atoms and R
2
 
represents a hydrogen atom, 
or R
1
 and R
2
 form with the nitrogen atom to which they are 
linked a saturated nitrogenous heterocycle with 5 or 6 

members optionally containing a second heteroatom, chosen 
from nitrogen, oxygen and sulphur atoms, optionally 

substituted by an alkyl radical having 1 to 4 carbon atoms, 
or by an oxo group, 
or R
1
 and R
2
 form a dialkylaminomethylene radical, each 
alkyl containing 1 to 4 carbon atoms, 
 
n is an integer at most equal to 18,
 
as well as the addition salts of the aforementioned. 
The compounds of general formula (I) as defined in claim 
1, corresponding to general formula (I'): 


 
in which R
1
 and R
2
, identical or different, represent: 

a hydrogen atom, a linear, branched or cyclic alkyl radical 
containing 1 to 8 carbon atoms, optionally substituted, an 

acyl radical having at most 12 carbon atoms, or an optionally  
 

substituted phenyl radical, 
or R
1
 represents a carbamoyl radical monosubstituted by an 
optionally substituted linear, branched or cyclic alkyl 

radical having at most 8 carbon atoms, or by an optionally 
substituted phenyl radical, and R
2
 represents a hydrogen 
atom, 
or R
1
 and R
2
 form with the nitrogen atom to which they 
are linked, a cyclic urea of the type 


n' being equal to 2 or 3, 
or R
1
 and R
2
 form a dimethylaminomethylene radical, 
n is equal at most to 7, 
 
as well as the addition salts of the aforementioned. 
The compounds of formula (I) as defined in claim 1 or 2, 
in which R
17
 is a hydroxyl radical and R'
17
 represents a 
hydrogen atom. 
The compounds of formula (I) as defined in claim 1, 2 or 
3 in which n is equal to 5 or 6. 
The compounds of formula (I) as defined in any one of 
claims 1 to 4, in which R
1
 and R
2
 represent a hydrogen atom. 
The compounds of formula (I) as defined in any one of 
claims 1 to 4, in which R
1
 and R
2
 represent a linear, 
branched or cyclic alkyl radical having at most 8 carbon 

atoms optionally substituted by one or more halogen atoms. 
The compounds of formula (I) as defined in any one of 
claims 1 to 4, in which R
1
 represents a hydrogen atom and R
2
 
represents a linear, branched or cyclic alkyl radical having 

at most 8 carbon atoms. 
The compounds of formula (I) as defined in any one of 
claims 1 to 4, in which R
1
 represents a carbamoyl radical 
monosubstituted by a linear, branched or cyclic alkyl radical 

containing 1 to 8 carbon atoms, or by a phenyl radical, each 
of these radicals being optionally substituted by halogen 

atoms and R
2
 represents a hydrogen atom.  
 
The compounds of formula (I) as defined in claim 1 of 
which the names follow: 


N-butyl-5-[4-(3,17beta-dihydroxy-estra-1,3,5(10)-trien-11beta-yl) 
phenoxy]
-pentanesulphonamide, 
N-butyl 5-[4-(3,17beta-dihydroxy-estra-1,3,5(10)-trien-11beta-yl) 
phenoxy]
-N-methyl-pentanesulphonamide, 
5-[4-(3,17beta-dihydroxy-estra-1,3,5(10)-trien-11beta-yl) 
phenoxy]
-N-(2,2,3,3,4,4,4-heptafluorobutyl)-N-methylpentanesulphonamide. 
Preparation process for the compounds of formula (I) as 
defined in claim 1, characterized in that a compound of 

formula (II): 

 
in which the phenol function is, if appropriate, protected, 

is subjected 

A) Either
 to the action of a halogenated derivative of 
formula (III): 


X-(CH
2
)
n
-SO
2
-NR
A
R'
A
 
in which X is a halogen atom, n has the meaning indicated in 

claim 1, R
A
 and R'
A
, identical or different, represent a 
hydrogen atom, an optionally substituted linear, branched or 

cyclic alkyl radical containing 1 to 8 carbon atoms, an acyl 
radical having at most 12 carbon atoms, an optionally 

substituted aryl or aralkyl radical, as defined in claim 1, 
it being understood that at least one of the substituents R
A
 
 

and R'
A
 is not a hydrogen atom, or form with the nitrogen to 
which they are linked a saturated nitrogenous heteroatom with 

5 or 6 members optionally containing a second heteroatom 
chosen from nitrogen, oxygen and sulphur atoms and optionally 

substituted by an alkyl group having 1 to 4 carbon atoms, in 
order to obtain a product of formula (IV): 


 
in which n, R
A
 and R'
A
 have the same meaning as previously, 
which is subjected to the action of an aromatization agent of 

ring A, and optionally of an acylation agent of the hydroxyl 
radical in position 3, in order to obtain a product of 

formula (I
A
), corresponding to the product of formula (I), in 
which R
1
=R
A
 and R
2
=R'
A
, 

 
 

and in which n, R
A
 and R'
A
 have the same meaning as 
previously, and R
3
 represents a hydrogen atom or an acyl 
group having at most 12 carbon atoms, which product of 

formula (I
A
) is subjected, if desired and if necessary, to 

one or more of the following reactions, in an appropriate 
order: 


reduction of the ketone function in position 17 
addition on the ketone function in position 17 of a metal 
complex of formula (X): 


M-R'
17a
 
in which M represents a metal atom and R'
17a
 has the same 
meaning as R'
17
 with the exception of a hydrogen atom, 
selective acylation in position 17 when R
17
 is a hydroxyl, 
alkylation or acylation of the hydroxyl radical in position 
3, 
saponification when R
3
 represents an acyl function, 
optional salification by an acid or a base 
B) Or
 to the action of an aromatization agent of the A ring 
and to a protection reaction of the hydroxyl radical in 

position 3, then to a selective elimination reaction of the 
protective group of the phenol in position 11, in order to 

obtain a product of formula (V): 

 
in which R
p
 represents a protective group, which is subjected 
to the action of a compound of formula (III'): 


X-(CH
2
)
n
-SO
2
-N=CH-N(Alk
1
)(Alk
2
)
 
 

X being a halogen atom, (Alk
1
) and (Alk
2
) being alkyl groups 
having 1 to 4 carbon atoms and n is equal at most to 18, then 

to a hydrolysis reaction of the imine formed, in order to 
obtain a compound of formula (VI): 


 
and in which n and R
p
 have the same meaning as previously, 
being able if appropriate, according to the nature of the R
p
 
group, to correspond to a product of formula (I), which 

product of formula (VI) is subjected, if desired and if 
necessary, to one or more of the following reactions, in an 

appropriate order: 

elimination reaction of the R
p
 protective group 
reduction of the ketone function in position 17 
addition on the ketone function in position 17 of a metal 
complex of formula (X): 


M-R'
17a
 
as defined previously, 
selective acylation in position 17 when R
17
 is a hydroxyl 
alkylation or acylation of the hydroxyl radical in position 
3 
action of a halide of formula (VII) 

R
B
-X
  
 

in which R
B
 is an optionally substituted alkyl radical having 
1 to 4 carbon atoms, or an acyl radical having at most 12 

carbon atoms and X represents a halogen atom in order to 
obtain the compound of formula (I
B
) corresponding to the 
product of formula (I) in which R
1
=H and R
2
=R
B
, 

 
and in which n, R
17
, R'
17
 and R
3
 have the meanings indicated 
in claim 1, 
action of an isocyanate of formula (VIII): 

R
C
-NCO
 
in which R
C
 represents a linear, branched or cyclic alkyl 
radical having at most 8 carbon atoms, an aryl or aralkyl 

radical as defined in claim 1, each of the radicals being 
optionally substituted in order to obtain the compound of 

formula (I
C
), corresponding to the product of formula (I) in 
which R
1
 represents a mono-substituted carbamoyl radical and 
R
2
 a hydrogen atom,  
 


 
and in which n, R
17
, R'
17
 and R
3
 have the meanings indicated 
in claim 1, 
action of a compound of formula (IX): 

(Alk
3
O)(Alk
4
O)CH-N(Alk
1
)(Alk
2
)
 
in which Alk
1
, Alk
2
, Alk
3
 and Alk
4
 are alkyl radicals having 
1 to 4 carbon atoms, in order to obtain the compound of 

formula (I
D
), corresponding to the product of formula (I) in 
which R
1
 and R
2
 form a dialkylaminomethylene group, 

 
and in which n, R
17
, R'
17
 and R
3
 have the meanings indicated 
in claim 1,  

 
alkylation or acylation of the product of formula (I
B
), by 
the action of a halide of formula (VII), in order to obtain a 

corresponding dialkylated, diacylated or alkylacylated 
sulphonamide, 
cyclization reaction of the product of formula (I
C
), when 
R
C
 is a -(CH
2
)
n
'-Hal radical, n' being equal to 2 or 3 and 
Hal represents a halogen atom, in order to obtain the product 

of formula (I'
C
) corresponding to the product of formula (I) 
in which R
1
 and R
2
 form with the nitrogen to which they are 
linked a cyclic urea of the type: 


optional salification by an acid or a base. 
Preparation process for the products of formula (I) as 
defined in claim 1, characterized in that the process is 

carried out in a similar way to claim 10 and in that a 
compound is used at the start corresponding to the compound 

of formula (II) as defined in claim 10 containing in position 
17 the R
17
 and R'
17
 substituents as defined in claim 1. 
As medicaments, the compounds of formula (I) as defined 
in any one of claims 1 to 8, as well as the pharmaceutically 

acceptable addition salts. 
As medicaments, the compounds of formula (I) defined in 
claim 9. 
The pharmaceutical compositions containing as active 
ingredient at least one of the medicaments defined in claim 

12 or 13. 
As intermediate products, the compounds of general 
formulae (IV) and (VI) as defined in claim 10. 
</CLAIMS>
</TEXT>
</DOC>
